-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network Market AnalysisChildren's drug safety is related to children's physical and mental health and growthWith the arrival of "June 1" Children's Day, the safety of children's medication has once again become the focus of public attentiondata show that China's children aged 0 to 14 accountforited to about 16.6% of the total population, the proportion of sick children to the total number of sick people has exceeded 20%, but the current shortage of children's special medicinesAs children's bodies are in the developmental stage, their particularity needs to be fully taken into account when taking medication, but there are few varieties, dosage forms and specifications available for childrenOf the more than 3,500 pharmaceutical preparations in China, only 1.7% are available for children."in addition to the shortage of children's special drugs, children's drug use also has improper drug specifications, high incidence of adverse reactions and other drug safety risks, need to attract the attention of the industry and the parent communityfocus on "61": children's drug use issues are concerned, drug machines will play an important role (Source: Pharmaceutical Network)children's drug use problem is being concerned
from the current overall situation, children's special drug shortage, safety issues are being concerned by the industry, and many parties are in the forceFor example, as consistency evaluations have advanced, more children's medications have been included in national centralized procurement effortsThrough the "price-for-quantity" principle to allow patients to buy more high-quality and low-cost drugs, reduce the burden of drug costsbecause children belong to a special group, coupled with the current clinical data of applicable drugs generally insufficient, so the industry also recommended that in the selection process of varieties should focus on the safety and effectiveness of varieties, the need for experts more fully demonstrated, if necessary, to take a comprehensive clinical evaluation of drugs to ensure the quality and safety of drugsthe current market for children's special drugs varieties and dosage forms are less, difficult to meet the needs of children's drugs, and sometimes even the phenomenon of out-of-stock, how to ensure the supply of children's medicine is also a problemIn this regard, some experts suggest that the market can be stable use of children's drug varieties into the pharmaceutical reserves, to ensure that the province's medical institutions clinical drug demandIn addition, children's medicine procurement can be considered comprehensively to mobilize the enthusiasm of enterprises to ensure the production and supply of children's medicinesthe new Drug Administration Act to encourage the development and innovation of medicines for children, support the development of new varieties, dosage forms and specifications of children's medicines in line with child's biological characteristics, and give priority to the review and approval of children's medicinesIn addition, the relevant departments of the State have recently launched a study on the legislation on children's drug use, and will conduct a nationwide study on the feasibility of legislation, widely solicit the views of all sectors of society, and speed up the work of children's drug use legislationwith multiple efforts, children's drug problems will gradually be alleviated, in the face of huge market demand, children's medicine will also usher in the releaseData show that the size of China's children's drug market in 2018 has reached nearly 78.607 billion yuan, an increase of 11.72 percent year-on-yearWith the liberalization of the "two-child" policy, as well as drug review and approval, health insurance policy and other policies to support children's drug research and development, the children's drug market prospects are broadThe market size of such drugs is expected to exceed 200 billion yuan in 2020 and 220 billion yuan by 2021Drug machine will provide support for children's drug research and development
in the context of policy support to encourage pharmaceutical companies to speed up the development of children's drugs, pharmaceutical equipment also need to assume corresponding responsibilitiesPharmaceutical equipment is the "heart" of pharmaceutical production, so it is necessary to combine the process characteristics of pharmaceutical stoics to manufactureBecause the production of children's drugs is more small batch, multi-batch, the process is relatively complex, pharmaceutical equipment enterprises only in-depth study, to create more reliable quality, higher precision of the drug machine products, in order to provide a strong tool support for children's drug research and developmentexperts pointed out that pediatric drugs are mainly divided into oral drugs and injectionsAmong them, oral medicine is basically a dosage type problem, injection is basically a dosage problem"What is now missing in pediatrics is a small dose of injectionsPreparation equipment enterprises should be in accordance with the needs of children's drugs, the development of more high-precision equipment for children to provide protection "
the author learned that science and technology will be the pharmaceutical equipment, most of the domestic pharmaceutical equipment has gradually realized automation, information, the next step will be towards the direction of intelligence Industry insiders believe that intelligent robots will play an important role in children's drug research and development, both in terms of accuracy and speed, have shown good results And robots can replace some tedious, repetitive work, allowing researchers to devote more time to more important tasks such as drug research and development also, intelligent equipment in terms of capacity will also be greatly increased Previously, there is a shortage of children's medicine, the news of off supply, mainly because of the national demand, coupled with the failure of pharmaceutical production equipment resulting in timely supply, some areas out of stock The industry believes that intelligent machine equipment can achieve capacity improvement, and reduce the occurrence of failures, to ensure the normal supply of products, to avoid out-of-stock and other conditions The conclusion children are the future of the motherland, and the issue of children's medication needs attention in the coming days of Children's Day Focusing on the problems of fewer children's pharmaceutical types and safety, the development of safe children's special drugs has become a problem that pharmaceutical companies need to pay attention to At the same time, upstream pharmaceutical production equipment also needs excellence, for children's drug research and development to provide protection As the industry says, "quality comes from design, the quality of drugs is not tested out, nor is it produced, is given by the design." If it is not a child-specific medicine, but an adult medicine, even if you are a very product, but you are not designed for children, in the use of children, it is still unsafe, because it is not in accordance with the child's health, psychology and other characteristics to do the design "